Equities

Hisamitsu Pharmaceutical Co Inc

Hisamitsu Pharmaceutical Co Inc

Actions
  • Price (EUR)24.20
  • Today's Change-0.600 / -2.42%
  • Shares traded0.00
  • 1 Year change-30.06%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Feb 29 2024202420232022
ASSETS
Cash And Short Term Investments125,321136,868142,431
Total Receivables, Net42,98339,75338,112
Total Inventory21,17618,92216,412
Prepaid expenses------
Other current assets, total4,5423,6313,221
Total current assets194,022199,174200,176
Property, plant & equipment, net49,46243,20939,069
Goodwill, net1,444----
Intangibles, net5,3879461,326
Long term investments67,12160,84552,519
Note receivable - long term------
Other long term assets3,5953,3413,503
Total assets328,779313,917302,858
LIABILITIES
Accounts payable16,26314,91813,225
Accrued expenses1,8311,3401,363
Notes payable/short-term debt1,0001,0001,000
Current portion long-term debt/capital leases421398372
Other current liabilities, total26,42324,92216,200
Total current liabilities45,93842,57832,160
Total long term debt6798971,088
Total debt2,1002,2952,460
Deferred income tax4,5181,8134,170
Minority interest2,2052,0421,717
Other liabilities, total10,56210,22110,555
Total liabilities63,90257,55149,690
SHAREHOLDERS EQUITY
Common stock8,4738,4738,473
Additional paid-in capital2,3612,3612,356
Retained earnings (accumulated deficit)242,912235,829236,446
Treasury stock - common(36993)(27196)(19527)
Unrealized gain (loss)25,45520,44518,711
Other equity, total22,66916,4546,709
Total equity264,877256,366253,168
Total liabilities & shareholders' equity328,779313,917302,858
Total common shares outstanding767880
Treasury shares - common primary issue9.427.425.43
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.